MIRA Pharmaceuticals, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MIRA research report →
About the company
MIRA Pharmaceuticals, Inc. operates as a biopharmaceutical enterprise currently in the clinical development phase. Its main objective involves the creation and market introduction of a novel synthetic tetrahydrocannabinol (THC) analog.
- CEO
- Erez Aminov
- IPO
- 2023
- Employees
- 2
- HQ
- Baltimore, MD, US
Price Chart
- Market Cap
- $39.70M
- P/E
- -0.66
- P/S
- 0.00
- P/B
- 4.24
- EV/EBITDA
- -3.56
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -140.83%
- ROIC
- -104.73%
- Revenue
- $0 · 0.00%
- Net Income
- $-10,442,485 · -32.98%
- EPS
- $-1.35 · -164.71%
- Op Income
- $-10,493,112
- FCF YoY
- 16.17%
- 52W High
- $2.45
- 52W Low
- $0.90
- 50D MA
- $1.00
- 200D MA
- $1.25
- Beta
- 1.49
- Avg Volume
- 122.17K
Get TickerSpark's AI analysis on MIRA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 12, 26 | Whalen Matthew Pratt | other | 50,000 |
| Jun 12, 26 | Del Giudice Matthew Paul | other | 50,000 |
| Jun 12, 26 | MacPherson Edward Clouston | other | 50,000 |
| Jun 12, 26 | Shekhat Denil Nanji | other | 50,000 |
| Jun 2, 26 | Mushak Andriy | other | 0 |
| Mar 30, 26 | Aminov Erez | other | 83,500 |
| Dec 17, 25 | Aminov Erez | other | 3,155,170 |
| Oct 16, 25 | Aminov Erez | other | 379,000 |
| Oct 16, 25 | Aminov Erez | other | 234,595 |
| Oct 1, 25 | Shekhat Denil Nanji | other | 22,378 |
Our MIRA coverage
Recent articles, reports, and earnings notes.
No research on MIRA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MIRA report →Similar companies
Peers in the same neighborhood.